imfinzi durvalumab biggest commercial | 0.98 | 1 | 5482 | 37 | 95 |
imfinzi durvalumab biggest company | 1.92 | 0.6 | 1376 | 34 | 44 |
imfinzi durvalumab biggest cost | 1.06 | 0.8 | 1636 | 31 | 38 |
imfinzi durvalumab biggest customer | 0.79 | 0.5 | 7878 | 35 | 83 |
imfinzi durvalumab biggest controversy | 1.28 | 0.9 | 2543 | 38 | 14 |
imfinzi durvalumab biggest competitor in cost | 1.01 | 0.2 | 7172 | 45 | 36 |
imfinzi durvalumab biggest collaboration | 0.91 | 1 | 1545 | 40 | 53 |
imfinzi durvalumab biggest comparison | 0.16 | 0.6 | 3179 | 37 | 33 |
imfinzi durvalumab biggest competitor | 0.63 | 0.7 | 8400 | 37 | 64 |
imfinzi durvalumab biggest clinical trial | 0.54 | 0.1 | 477 | 41 | 30 |
imfinzi durvalumab biggest challenge | 2 | 0.4 | 1348 | 36 | 89 |
durvalumab imfinzi package insert | 0.79 | 0.3 | 3779 | 33 | 19 |
imfinzi durvalumab side effects | 1.9 | 0.9 | 3943 | 31 | 59 |
j code for imfinzi durvalumab | 0.12 | 0.5 | 2641 | 29 | 34 |
imfinzi biggest competitor in clinical trials | 0.33 | 0.2 | 9930 | 45 | 65 |
imfinzi biggest competitor in cost | 0.96 | 0.1 | 1267 | 34 | 50 |